Treatment of aspirin-intolerant asthma with antileukotrienes.
Dahlén
B
B
Division of Respiratory Medicine, Department of Medicine, Karolinska Hospital, Karolinska Institutet, Stockholm, Sweden. barbro.dahlen@medks.ki.se
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D016084:Bronchoconstriction / Q000187:drug effects / Q000502:physiology; D002986:Clinical Trials as Topic; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D015289:Leukotrienes / Q000502:physiology
D018927:Anti-Asthmatic Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018836:Inflammation Mediators; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D001241:Aspirin